SNMMI said it is disappointed with a recent CMS draft decision to restrict coverage of beta-amyloid PET imaging to one scan per patient. In addition, the scan must be part of a clinical trial under a coverage-with-evidence development program. The group argues that data support broader coverage of the scan and that testing improves patient management. SNMMI is developing an education program for doctors regarding referral for and interpretation of the test.

Related Summaries